Fig. 1.
Fig. 1. Disease progression after PBSCT. / Cumulative incidence of disease progression after allogeneic PBSCT with RIC in patients with (n = 24) and without (n = 13) GVHD (acute grade II-IV or chronic GVHD). The 1-year incidence of disease progression in patients with and without GVHD was 13% (95% CI, 4%-34%) and 58% (95% CI, 36%-96%), respectively (P = .008).

Disease progression after PBSCT.

Cumulative incidence of disease progression after allogeneic PBSCT with RIC in patients with (n = 24) and without (n = 13) GVHD (acute grade II-IV or chronic GVHD). The 1-year incidence of disease progression in patients with and without GVHD was 13% (95% CI, 4%-34%) and 58% (95% CI, 36%-96%), respectively (P = .008).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal